-
Signature
-
/s/ Elizabeth Villalobos, Attorney-in-Fact for Nikesh Arora
-
Issuer symbol
-
PANW
-
Transactions as of
-
20 Aug 2024
-
Net transactions value
-
-$49,146,742
-
Form type
-
4
-
Filing time
-
22 Aug 2024, 16:30:08 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PANW |
Common Stock |
Options Exercise |
$10,796,685 |
+163,174 |
+25% |
$66.17 |
803,168 |
20 Aug 2024 |
Direct |
|
| transaction |
PANW |
Common Stock |
Sale |
$26,403,853 |
-72,058 |
-9% |
$366.42 |
731,110 |
20 Aug 2024 |
Direct |
F1, F2 |
| transaction |
PANW |
Common Stock |
Sale |
$14,165,552 |
-38,541 |
-5.3% |
$367.54 |
692,569 |
20 Aug 2024 |
Direct |
F1, F3 |
| transaction |
PANW |
Common Stock |
Sale |
$17,571,818 |
-47,693 |
-6.9% |
$368.44 |
644,876 |
20 Aug 2024 |
Direct |
F1, F4 |
| transaction |
PANW |
Common Stock |
Sale |
$1,802,205 |
-4,882 |
-0.76% |
$369.15 |
639,994 |
20 Aug 2024 |
Direct |
F1, F5 |
| holding |
PANW |
Common Stock |
|
|
|
|
|
16,005 |
20 Aug 2024 |
See footnote |
F6 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PANW |
Stock Option (right to buy) |
Options Exercise |
$0 |
-163,174 |
-7.1% |
$0.000000 |
2,148,252 |
20 Aug 2024 |
Common Stock |
163,174 |
$66.17 |
Direct |
F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: